Secondary Logo

Journal Logo

April 2010 - Volume 33 - Issue 2
pp: 111-215

Gastrointestinal


S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5-Fluorouracil, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach

Blanke, Charles D.; Chansky, Kari; Christman, Kathy L.; More

American Journal of Clinical Oncology. 33(2):117-120, April 2010.

Head & Neck


Concomitant Cisplatin, Paclitaxel, and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: Comparison of Two Different Schedules

Moreno-Jiménez, Marta; Valero, Jeannette; María López-Picazo, José; More

American Journal of Clinical Oncology. 33(2):137-143, April 2010.

Thoracic


Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy

William, William N. Jr; Khuri, Fadlo R.; Fossella, Frank V.; More

American Journal of Clinical Oncology. 33(2):148-152, April 2010.

Genitourinary


Optimal Equations for Describing the Relationship Between Prostate Volume, Number of Sources, and Total Activity in Permanent Prostate Brachytherapy

Aronowitz, Jesse N.; Michalski, Jeff M.; Merrick, Gregory S.; More

American Journal of Clinical Oncology. 33(2):164-167, April 2010.


Cutaneous


Soft Tissue


Endocrine


Reports of Clinical Benefit of Plitidepsin (Aplidine), a New Marine-Derived Anticancer Agent, in Patients With Advanced Medullary Thyroid Carcinoma

Le Tourneau, Christophe; Faivre, Sandrine; Ciruelos, Eva; More

American Journal of Clinical Oncology. 33(2):132-136, April 2010.

Metastatic Disease